T. Rowe Price Investment Management, Inc. Neogenomics Inc Put Options Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$220 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$159 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$68.9 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$68.8 Million0.13% of portfolio
-
State Street Corp Boston, MA5.2MShares$58.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.41B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...